1. 1024. Impact of Treatment Adherence on Efficacy of DTG/3TC and DTG + TDF/FTC: Pooled Analysis of the GEMINI 1 and 2 Clinical Trials. (31st December 2020) Authors: Ait-Khaled, Mounir; Man, Choy; Sievers, Jorg; Grove, Richard; Wynne, Brian; Urbaityte, Rimgaile; van Wyk, Jean A; Madero, Juan G Sierra; Gulminetti, Roberto; Estrada, Vicente; Hagins, Debbie; Zolopa, Andrew; Tsai, Hung-Chin Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes. (March 2018) Authors: Ferrer, Pedro E; Bloch, Mark; Roth, Norman; Finlayson, Robert; Baker, David; Koh, Ken; Orth, David; Urbaityte, Rimgaile; Brown, Dannae; Drummond, Fraser Journal: International journal of STD & AIDS Issue: Volume 29:Number 3(2018) Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure. Issue 1 (11th December 2018) Authors: Stainsby, Chris M.; Perger, Teodora M.; Vannappagari, Vani; Mounzer, Karam C.; Hsu, Ricky K.; Henegar, Cassidy E.; Oyee, James; Urbaityte, Rimgaile; Lane, Charlotte E.; Carter, Lindsay M.; Pakes, Gary E.; Shaefer, Mark S. Journal: Pharmacotherapy Issue: Volume 39:Issue 1(2019) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials. (20th April 2018) Authors: Nan, Cassandra; Shaefer, Mark; Urbaityte, Rimgaile; Oyee, James; Hopking, Judy; Ragone, Leigh; Perger, Teodora; Win, Beta; Vangerow, Harald; McCoig, Cynthia; Vannappagari, Vani Journal: Open forum infectious diseases Issue: Volume 5:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials. (4th October 2017) Authors: Nan, Cassandra; Shaefer, Mark S; Urbaityte, Rimgaile; Oyee, James; Hopking, Judy; Ragone, Leigh; McCoig, Cynthia; Vannappagari, Vani Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. (1st May 2020) Authors: Eron, Joseph; Hung, Chien-Ching; Baril, Jean-Guy; Slim, Jihad; Falcó, Vicenç; Bogner, Johannes; Maggiolo, Franco; Mills, Anthony; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Underwood, Mark; Tenorio, Allan R.; Pappa, Keith A.; Wynne, Brian; Koteff, Justin; Gartland, Martin; Smith, Kimberly ... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 84:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. (1st March 2020) Authors: Cahn, Pedro; Madero, Juan Sierra; Arribas, José R.; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E.; Hung, Chien-Ching; Rockstroh, Jürgen K.; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Brandon, Daisy J.; Underwood, Mark; Tenorio, Allan R.; Pappa, Keith A.; Wynne, ... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 83:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection. (1st January 2022) Authors: Cahn, Pedro; Sierra Madero, Juan; Arribas, José R.; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E.; Hung, Chien-Ching; Rockstroh, Jürgen K.; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Brandon, Daisy J.; Underwood, Mark; Pappa, Keith A.; Curtis, Lloyd; Smith, Kimb... Journal: AIDS Issue: Volume 36:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection. (1st January 2022) Authors: Cahn, Pedro; Sierra Madero, Juan; Arribas, José R.; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E.; Hung, Chien-Ching; Rockstroh, Jürgen K.; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Brandon, Daisy J.; Underwood, Mark; Pappa, Keith A.; Curtis, Lloyd; Smith, Kimb... Journal: AIDS Issue: Volume 36:Number 1(2022) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗